BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 8640936)

  • 1. Exposure of DMBA-treated female rats in a 50-Hz, 50 microTesla magnetic field: effects on mammary tumor growth, melatonin levels, and T lymphocyte activation.
    Mevissen M; Lerchl A; Szamel M; Löscher W
    Carcinogenesis; 1996 May; 17(5):903-10. PubMed ID: 8640936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
    Thun-Battersby S; Mevissen M; Löscher W
    Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on pineal function and DMBA-induced breast cancer formation in rats during exposure to a 100-mG, 50 Hz magnetic field.
    Mevissen M; Lerchl A; Löscher W
    J Toxicol Environ Health; 1996 Jun; 48(2):169-85. PubMed ID: 8642624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A histopathological study on alterations in DMBA-induced mammary carcinogenesis in rats with 50 Hz, 100 muT magnetic field exposure.
    Baum A; Mevissen M; Kamino K; Mohr U; Löscher W
    Carcinogenesis; 1995 Jan; 16(1):119-25. PubMed ID: 7834796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceleration of mammary tumorigenesis by exposure of 7,12-dimethylbenz[a]anthracene-treated female rats in a 50-Hz, 100-microT magnetic field: replication study.
    Mevissen M; Häussler M; Lerchl A; Löscher W
    J Toxicol Environ Health A; 1998 Mar; 53(5):401-18. PubMed ID: 9515942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor promotion in a breast cancer model by exposure to a weak alternating magnetic field.
    Löscher W; Mevissen M; Lehmacher W; Stamm A
    Cancer Lett; 1993 Jul; 71(1-3):75-81. PubMed ID: 8364901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear relationship between flux density and tumor co-promoting effect of prolonged magnetic field exposure in a breast cancer model.
    Löscher W; Mevissen M
    Cancer Lett; 1995 Sep; 96(2):175-80. PubMed ID: 7585454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of weak alternating magnetic fields on nocturnal melatonin production and mammary carcinogenesis in rats.
    Löscher W; Wahnschaffe U; Mevissen M; Lerchl A; Stamm A
    Oncology; 1994; 51(3):288-95. PubMed ID: 8196914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic field exposure increases cell proliferation but does not affect melatonin levels in the mammary gland of female Sprague Dawley rats.
    Fedrowitz M; Westermann J; Löscher W
    Cancer Res; 2002 Mar; 62(5):1356-63. PubMed ID: 11888905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in ornithine decarboxylase activity in the rat mammary gland after different periods of 50 Hz magnetic field exposure.
    Mevissen M; Häussler M; Löscher W
    Bioelectromagnetics; 1999 Sep; 20(6):338-46. PubMed ID: 10453061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 13 week magnetic field exposures on DMBA-initiated mammary gland carcinomas in female Sprague-Dawley rats.
    Anderson LE; Boorman GA; Morris JE; Sasser LB; Mann PC; Grumbein SL; Hailey JR; McNally A; Sills RC; Haseman JK
    Carcinogenesis; 1999 Aug; 20(8):1615-20. PubMed ID: 10426815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of magnetic fields on mammary tumor development induced by 7,12-dimethylbenz(a)anthracene in rats.
    Mevissen M; Stamm A; Buntenkötter S; Zwingelberg R; Wahnschaffe U; Löscher W
    Bioelectromagnetics; 1993; 14(2):131-43. PubMed ID: 8494555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Studies of Magnetic Field Promotion (DMBA Initiation) in Female Sprague-Dawley Rats (Whole-body Exposure/Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Aug; 489():1-148. PubMed ID: 12563342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Power frequency magnetic fields increase cell proliferation in the mammary gland of female Fischer 344 rats but not various other rat strains or substrains.
    Fedrowitz M; Löscher W
    Oncology; 2005; 69(6):486-98. PubMed ID: 16424678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do cocarcinogenic effects of ELF electromagnetic fields require repeated long-term interaction with carcinogens? Characteristics of positive studies using the DMBA breast cancer model in rats.
    Löscher W
    Bioelectromagnetics; 2001 Dec; 22(8):603-14. PubMed ID: 11748679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex effects of long-term 50 Hz magnetic field exposure in vivo on immune functions in female Sprague-Dawley rats depend on duration of exposure.
    Mevissen M; Häussler M; Szamel M; Emmendörffer A; Thun-Battersby S; Löscher W
    Bioelectromagnetics; 1998; 19(4):259-70. PubMed ID: 9581968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure of rats to a 50-Hz, 100 muTesla magnetic field does not affect the ex vivo production of interleukins by activated T or B lymphocytes.
    Häussler M; Thun-Battersby S; Mevissen M; Löscher W
    Bioelectromagnetics; 1999; 20(5):295-305. PubMed ID: 10407515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure of female rats to a 100-microT 50 Hz magnetic field does not induce consistent changes in nocturnal levels of melatonin.
    Löscher W; Mevissen M; Lerchl A
    Radiat Res; 1998 Nov; 150(5):557-67. PubMed ID: 9806598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure of Fischer 344 rats to a weak power frequency magnetic field facilitates mammary tumorigenesis in the DMBA model of breast cancer.
    Fedrowitz M; Löscher W
    Carcinogenesis; 2008 Jan; 29(1):186-93. PubMed ID: 17916910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 26 week magnetic field exposures in a DMBA initiation-promotion mammary gland model in Sprague-Dawley rats.
    Boorman GA; Anderson LE; Morris JE; Sasser LB; Mann PC; Grumbein SL; Hailey JR; McNally A; Sills RC; Haseman JK
    Carcinogenesis; 1999 May; 20(5):899-904. PubMed ID: 10334209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.